ArticleChinese medical journal2026

Efficacy and safety of chemotherapy alone or in combination with immune checkpoint inhibitors as the first-line treatment for patients with advanced HER2 -mutant non-small cell lung cancer: A multi-center retrospective study.

Chenyi Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.